Anne Burger 

  •                                 
    Extbase Variable Dump
    'distribution:BiomSpeaker.html' (29 chars)
    
                            
  •                                     
    Extbase Variable Dump
    'fileadmin/Webdata/Uploads/Veranstaltungen/2025/BayOConnect_2025/Speaker/Burg
     er_300x300.jpg    ' (90 chars)
    
                                
  •                                     
    Extbase Variable Dump
    'Anne Burger' (11 chars)
    
                                
  •                                     
    Extbase Variable Dump
    'CFO, CatalYm' (12 chars)
    
                                
  •                                     
    Extbase Variable Dump
    'Anne brings more than 15 years of experience in financial operations at biot
     ech and medtech companies across Europe.  Currently she serves as Chief Fina
     ncial Officer at CatalYm and Topas Therapeutics.  Throughout her career, Ann
     e has been responsible for multiple corporate fundraising, trade sales, prep
     aring IPOs and licensing deals in several senior executive and advisory role
     s.  Before, she served as CFO and Co-Founder of Breath Therapeutics GmbH, wh
     ere she was instrumental in securing the financing (EUR 43.5million) as well
      as executing the sale of the company to Zambon S.p.A. with a deal value up 
     to EUR 500 million. As CFO of Rigontec, Anne played an active role in execut
     ing the sale of Rigontec to MSD (known as Merck & Co. in North America), a d
     eal worth up to EUR 460 million.    ' (792 chars)